Literature DB >> 17409126

Use of the QuantiFERON TB Gold test as part of a screening programme in patients with RA under consideration for treatment with anti-TNF-alpha agents: the Newcastle (UK) experience.

A Pratt, K Nicholl, L Kay.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17409126     DOI: 10.1093/rheumatology/kem064

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  8 in total

1.  Comparison of tuberculin skin test and QuantiFERON-TB gold in tube test in patients with chronic inflammatory diseases living in a tuberculosis endemic population.

Authors:  Feride Gogus; Zafer Günendi; Resul Karakus; Zeynep Erdogan; Kenan Hizel; Fatma Atalay
Journal:  Clin Exp Med       Date:  2009-12-01       Impact factor: 3.984

2.  Repeated tuberculin skin testing following therapy with TNF-alpha inhibitors.

Authors:  Inbal Fuchs; Lone Avnon; Tamar Freud; Mahmoud Abu-Shakra
Journal:  Clin Rheumatol       Date:  2008-09-16       Impact factor: 2.980

3.  Etanercept in the treatment of plaque psoriasis.

Authors:  Thao U Nguyen; John Koo
Journal:  Clin Cosmet Investig Dermatol       Date:  2009-05-19

4.  The Performance of Quantiferon TB Gold In-Tube as a Screening Tool in Paediatric Rheumatology prior to Initiation of Infliximab: A Single Centre's Experience.

Authors:  Despoina Maritsi; Muthana Al-Obadi; Paul A Brogan; Despina Eleftheriou; Garth L J Dixon
Journal:  ISRN Rheumatol       Date:  2011-08-15

5.  Identification of latent tuberculosis infection in rheumatic patients under consideration for treatment with anti-TNF-α agents.

Authors:  Jolanta Paluch-Oleś; Agnieszka Magryś; Maria Kozioł-Montewka; Arkadiusz Koszarny; Maria Majdan
Journal:  Arch Med Sci       Date:  2013-02-21       Impact factor: 3.318

Review 6.  Screening for tuberculosis infection prior to initiation of anti-TNF therapy.

Authors:  Ajit Lalvani; Kerry A Millington
Journal:  Autoimmun Rev       Date:  2008-08-13       Impact factor: 9.754

7.  Serial QuantiFERON-TB Gold testing in patients with psoriasis treated with ustekinumab.

Authors:  Chuan-Yu Hsiao; Hsien-Yi Chiu; Ting-Shun Wang; Tsen-Fang Tsai
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

8.  The seroconversion rate of QuantiFERON-TB Gold In-Tube test in psoriatic patients receiving secukinumab and ixekizumab, the anti-interleukin-17A monoclonal antibodies.

Authors:  Chen-Yu Wu; Hsien-Yi Chiu; Tsen-Fang Tsai
Journal:  PLoS One       Date:  2019-12-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.